There are no reported significant differences in clinical or histopathological findings or disease outcomes in ANA-positive and ANA-negative patients; however, ANA-positive patients tend to have higher IgG levels and higher rates of other autoimmune conditions [10]. The gene discussed is BTG3; the disease is Autoimmunity.